In high-temperature poultry houses where ambient wet-bulb temperatures exceed 24°C, the water-administered route for Qingshu Powder becomes a dose-delivery problem driven by variable drinking water intake rather than fixed feed consumption. The API is a hygroscopic botanical matrix; milled lots are specified with loss on drying ≤5.0% under Ph. Eur. 2.2.32 because residual moisture above 5.5% accelerates particle bridging in the screw feeder and reduces cold-water dispersibility. A water-soluble powder intermediate is produced by passing the API through a 180 µm stainless steel sieve (Retsch AS 200 or equivalent, amplitude 2.0 mm, 5 min) and then charging a 500 L V-blender at 65% fill with 20.0% w/w Qingshu Powder, 60.0% w/w anhydrous glucose, and 20.0% w/w citric acid. Batch record data from pilot runs show blend uniformity at ten sampling points with relative standard deviation ≤5.0% after 20 min at 22 rpm; increasing fill to 75% produces dead zones at the shell ends and raises RSD above 8.0%. A dispersal test in a 1 L beaker with 1.0 g material at 25°C passes if no visible agglomerates remain after 5 min of stirring at 200 rpm. The pH of a 1.0 g/L reconstituted solution is adjusted to 3.8–4.2 with citric acid to reduce microbial growth in standing water lines and to solubilize basic low-molecular-weight fractions. The addition ratio in final drinking water is 0.25–1.0 g/L depending on species age, but the fixed sachet formulation above is premixed at 20.0% w/w active powder to allow producer-level dilution. Terminal product types include 100 g, 500 g, and 1 kg laminated foil sachets with desiccant sachets, packaged at 40% RH to prevent caking.

Uniformity of dosage units of the reconstituted solution is not measured directly; instead, the dry sachet blend must meet Ph. Eur. 2.9.40 acceptance value ≤15.0 before packaging, and individual sachet mass is controlled by Ph. Eur. 2.9.5 with deviation limits of ±5.0%. Microbial quality is tested per Ph. Eur. 2.6.12; total aerobic microbial count ≤10⁴ CFU/g and total yeast and mold count ≤10² CFU/g are applied because the product is administered via drinking water rather than injected. Hard water above 400 mg/L CaCO3 produces a visible calcium-phenolic precipitate that blocks nipple drinkers; the sachet insert therefore specifies softened water or a 0.1% w/v citric acid preflush when total hardness exceeds 400 mg/L. The main production failure observed in batch records is sachet sealing with high residual air above 5.0%, which accelerates moisture transfer and browning at 40°C accelerated storage.

What Governs Homogeneity Limits in Qingshu Powder Premix Production?

In swine feed manufacturing, Qingshu Powder is introduced as a medicated premix intermediate rather than as a pure API, because handling losses and static charge from the botanical dust fraction become unacceptable when direct addition to a finished feed mixer is attempted. Compliance for this route is defined by Regulation (EU) 2019/4 for medicated feed, 21 CFR Part 225 CGMP for medicated feeds, and ISO 22000:2018 for feed safety management; carryover control must be validated by swab analysis at the feed mill after each batch. A 5.0% w/w premix is assembled by adding 10.0–20.0 kg Qingshu Powder to 100 kg calcium carbonate/lactose carrier in a 600 L ribbon mixer fitted with a spray bar for vegetable oil at 2.0% w/w to bind the API dust and reduce segregation. The addition ratio in the finished feed is 0.5–1.0 kg per 1000 kg when the 5.0% premix is metered at 10–20 kg/tonne; this must be recalculated if the API assay value falls outside 95–105% of the label claim. Stepwise dilution is used in three stages: 1:3 API-to-carrier, then 1:9, then 1:27, with 8–10 min mixing per stage at 12 rpm. Sampling at ten ports with a closed thief shows blend uniformity RSD ≤5.0% by NIR; batches with RSD >8.0% are rejected or re-mixed because segregation in the downstream feed bin transfers into finished feed. Carryover swab limits in the mixer and downstream conveying line are set at ≤0.1% of the next batch API concentration for contact surfaces. Terminal product forms include 1 kg foil pouches, 5 kg and 25 kg polypropylene-lined paper bags, and bulk tote systems. Premix storage at 25°C and 60% RH must not exceed 24 months; opened bags are to be used within 30 days because the API absorbs moisture and may develop clumps that impede metering augers.

Drench formulations for cattle and sheep depend on sedimentation stability after reconstitution and on pH-dependent complexation between polyphenolic fractions in Qingshu Powder and salivary proteins at pH >7.0. The development specification therefore fixes the oral drench at pH 5.5–6.5, with a 5.0–15.0% w/v loading of Qingshu Powder in a vehicle consisting of 10.0% v/v propylene glycol, 5.0% v/v glycerol, and 0.9% w/v sodium chloride in purified water; citric acid monohydrate is used for pH adjustment. As an oral veterinary medicinal product, the drench falls under Regulation (EU) 2019/6 marketing authorization requirements, and batch release testing includes Ph. Eur. 2.9.40 uniformity of dosage units, Ph. Eur. 2.2.3 pH, and Ph. Eur. 2.2.10 rotational viscometer measurement at 25°C and spindle speed 60 rpm to avoid pump failure in automatic drenching guns above 300 mPa·s. The manufacturing sequence uses a high-shear bottom-valve mixer at rotor tip speed 12 m/s for 15 min at 40°C, followed by cooling to 20°C and passage through a 80 µm nylon filter to remove coarse fibers. Settling after 24 h is controlled at ≤5.0% by visual sediment volume; batches exceeding this limit are returned for increased glycine or sodium carboxymethylcellulose addition at 0.5% w/v. The filled product is filled into 1 L and 5 L HDPE bottles with induction-sealed caps, with fold-over dispensing caps for automatic syringes. The main incompatibility observed in production is precipitation with bentonite clay and with sodium bicarbonate boluses administered concurrently; water hardness above 400 mg/L CaCO3 also produces a cloudy suspension that clogs the drenching gun check valve.

Injectable Solution Filtration and Pyrogen Control

Injectable solution manufacture is not a direct dissolution of the botanical API in water for injection; the sequence must remove fibers, colloidal polysaccharides, and pyrogens that are acceptable in oral routes but not in parenteral products. The sterile route is governed by Ph. Eur. 2.6.1 for sterility, Ph. Eur. 2.6.14 for bacterial endotoxins, Ph. Eur. 2.9.19 for sub-visible particle counts, and Ph. Eur. 5.1.1 for terminal sterilization when stability data support it. A development loading of 0.5–2.0% w/v purified Qingshu Powder is dissolved or dispersed in water for injection at 60°C; pH is adjusted to 6.0–7.0 with 0.1 M sodium citrate, and tonicity is set with 0.9% w/v sodium chloride. The solution is cooled to 25°C, held for 30 min to allow precipitation, and filtered through a 0.45 µm PVDF prefilter followed by a 0.22 µm polyethersulfone final filter. Terminal sterilization at 121°C for 15 min is applied only if marker compound loss is ≤10% and pH drift is ≤0.2 units; otherwise, aseptic filling is used because published data for terminal sterilization of this specific botanical configuration is limited. The filled product is packaged in 10 mL, 50 mL, and 100 mL Type I glass vials with siliconized butyl stoppers. Phenolic preservatives are avoided because they induce visible precipitation in the polysaccharide fraction; if a multi-dose formulation is required, preservative compatibility must be revalidated with pH, turbidity, and sub-visible particle counts over 28 days at 25°C.

On production-scale filling lines, the limiting failure mode encountered with Qingshu Powder parenteral batches is filter fouling: a 0.22 µm membrane may blind within 20 min if pre-filtration through 0.45 µm is omitted, because residual colloidal material loads the membrane surface. Vial stopper coring and glass delamination are controlled by depyrogenation at 250°C for 30 min in a hot air tunnel and by using coated stoppers. Endotoxin limits are set by dose; for a 10 mL injection given to a 500 kg bovine at 1.0 mL/50 kg, the release limit ≤0.5 EU/mL provides a safety factor under 2.0 EU/kg dose. Batch-to-batch variation in the API extract viscosity from 1.8–2.6 mPa·s is acceptable if the final filter differential pressure remains below 1.0 bar; higher differential pressure indicates the need for additional centrifugation at 10,000 × g for 10 min before filtration.

Pass the spray-dried Qingshu Powder through a 180 µm mesh before dry granulation, because the tapped bulk density fluctuates between 0.38 g/mL and 0.52 g/mL across supplier lots and directly influences die-fill depth on a rotary tablet press. Tablet and capsule processing is selected for companion animals when dosing accuracy is required and the pet owner cannot administer a powder or drench. The direct-compression loading range is 10.0–30.0% w/w Qingshu Powder; above 30.0% w/w, the botanical fiber fraction lowers tensile strength and increases capping at the tablet crown during high-speed compression. A typical tablet core contains 25.0% w/w Qingshu Powder, 63.0% w/w pregelatinized starch, 5.0% w/w croscarmellose sodium, 1.0% w/w magnesium stearate, and 6.0% w/w colloidal silicon dioxide. The blend is lubricated for 3 min at 15 rpm in a bin blender; longer lubrication time above 5 min reduces disintegration due to hydrophobic magnesium stearate film formation. Tablet compression is performed on a 27-station rotary press at 30–45 rpm and 15–25 kN compression force, with target hardness 60–100 N and friability ≤1.0% per Ph. Eur. 2.9.7. Disintegration must be ≤15 min per Ph. Eur. 2.9.1, and dissolution at 37°C in 0.1 M hydrochloric acid requires Q ≥80% at 30 min per Ph. Eur. 2.9.3. Capsules use the same granulated material at 30.0–45.0% w/w active powder filled to a target fill weight of 250 mg or 500 mg in gelatin or HPMC shells; terminal product types include 250 mg and 500 mg tablets and 0.5 g capsules in 10-count blister packs. For commercial registration as a veterinary tablet/capsule, the manufacturing authorization follows Regulation (EU) 2019/6 and Ph. Eur. 2.9.40 uniformity of dosage units with acceptance value ≤15.0, while residual solvents are tested per VICH GL18. The main batch failure is lamination on the rotary press when storage humidity rises above 60% RH; the granulation area is therefore maintained at 30–40% RH and 20–25°C.

When Extruded Aquafeed Pellets Require Post-Extrusion Coating

Extruded aquafeed pellets leave the conditioner at 85–95°C and must cool to 60°C before vacuum coating; Qingshu Powder is not added to the extrusion mash because the residence time at high moisture and 85°C degrades heat-labile marker compounds and reduces batch-to-batch assay. The coating route is used where jurisdictional approval exists for botanical feed additives in aquatic species; compliance is aligned with ISO 22000:2018 and CAC/RCP 52-2003 hygiene principles, with final feed pathogen testing by validated PCR method. Addition ratio for the final coated feed is 0.1–0.5% w/w of a microencapsulated Qingshu Powder in fish oil, applied in a vacuum coater at 0.08 MPa vacuum for 8–10 min after the pellets have cooled to 60°C. The coating emulsion is prepared by dispersing the API into 2.0% w/w lecithin and fish oil at 40°C, then passing through a 20 µm screen to prevent nozzle clogging. Pellet durability after coating is measured with a Holmen tester for 30 s; fines ≤2.0% are acceptable. Leach loss in 25°C seawater after 30 min is controlled at ≤10% of the active marker, because higher loss indicates insufficient oil encapsulation and leads to water turbidity. Terminal product types are 2 mm and 4 mm extruded floating pellets packaged in 25 kg reinforced paper or polywoven bags. The main process incompatibility is with high-temperature post-extrusion drying above 80°C; drying is therefore limited to 70°C for 15 min.